Hospital pharmacy and the patient

Proceedings of a symposium held at the University of York, England, 7–9 July 1982

Buch | Softcover

187 Seiten

2012 | Softcover reprint of the original 1st ed. 1983
Springer (Verlag)
978-94-011-9725-0 (ISBN)

Artikel merken

The development of new technology means that compromised patients previously confined to hospital may now be treated at home. Those patients receiving intravenous feeding, cytotoxic drugs and new insulin therapy, are fully trained by the health-care professionals (doctors, pharmacists and nurses) to encourage self-reliance and understanding which are vital to success. There are hazards in treating these patients in the home environment, e.g. microbiological risks which are currently being evaluated, failure of equipment, and social problems as patients adjust to a new life in the community. Neverthless, the balance of benefits favour restoration of the patient to a self-reliant positive life at home. The delivery of this important new dimension in therapy was described at a symposium held in the University of York by innovators in the field. Discussion enabled the core of knowledge and experience developed by multi-disciplinary teams to be shared. The problems of supplying parenteral nutrition and medication for the compromised patient in the home and the family situation were aired and solutions presented. The special care for hospital out-patients receiving cytotoxic drug therapy and safe procedures for staff handling these agents was presented and together with responses to questions indicated the direction for UK hospital pharmacists to follow. More information is needed and it is hoped that this account of these proceedings will stimulate interest in these aspects of health care.

Section One Parenteral Therapy for the Patient at Home.- Chairman’s introduction.- 1 Cytotoxic therapy — developing a home intravenous service.- 2 Current therapeutic role of continuous insulin delivery systems.- 3 Care of the home parenteral nutrition patient.- 4 Is providing the regimen sufficient?.- Discussion.- Section Two Hazards, Risks and Responsibilities.- Chairman’s introduction.- 5 Handling cytotoxic drugs — health and safety hazards.- 6 Microbiological risks for the compromised patient at home.- 7 Home parenteral therapy and the general practice pharmacist.- 8 Home parenteral therapy and the hospital pharmacist.- Discussion.- Section Three New Approaches in Practice.- 9 An evaluation of the use of case studies in clinical pharmacy training.- Discussion.- 10 An integrated approach to ward pharmacy.- Discussion.- 11 Ward and clinical pharmacy — a comparison with Holland.- Discussion.- 12 The stability of diluted betamethasone 17-valerate topical preparations.- Discussion.- 13 A case study in nutritional support.- Discussion.- 14 The introduction of a cytotoxic reconstitution and additive service in a regional chemotherapy centre.- Discussion.- Section Four Drug Selection and Evaluation.- Chairman’s introduction.- 15 Hospital pharmacy and clinical pharmacokinetics — is academia in touch?.- 16 Theophylline therapy: the need for pharmacy involvement.- 17 Pharmacokinetics in the hospital pharmacy.- 18 Practising drug evaluation.- Discussion.- Closing address.

Zusatzinfo	11 Illustrations, black and white; XII, 187 p. 11 illus.
Verlagsort	Dordrecht
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizin / Pharmazie ► Allgemeines / Lexika
	Medizin / Pharmazie ► Pflege
	Medizin / Pharmazie ► Pharmazie ► PTA / PKA
ISBN-10	94-011-9725-3 / 9401197253
ISBN-13	978-94-011-9725-0 / 9789401197250
Zustand	Neuware